{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:57:47Z","timestamp":1792180667229,"version":"4.4.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113403","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T06:30:51Z","timestamp":1729492251000},"page":"113403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P2","title":["Empagliflozin protects the heart from atrial fibrillation in rats through inhibiting the NF-\u03baB\/HIF-1\u03b1 regulatory axis and atrial remodeling"],"prefix":"10.1016","volume":"143","author":[{"given":"Hussein","family":"Badreldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Elshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"El-Karef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2024.113403_b0005","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.jvca.2015.05.058","article-title":"Atrial fibrillation: pathophysiology and therapeutic options","volume":"29","author":"Bhatt","year":"2015","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0010","doi-asserted-by":"crossref","first-page":"16016","DOI":"10.1038\/nrdp.2016.16","article-title":"Atrial fibrillation","volume":"2","author":"Lip","year":"2016","journal-title":"Nat. Rev.Disease Primers"},{"issue":"6","key":"10.1016\/j.intimp.2024.113403_b0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41569-022-00820-8","article-title":"Epidemiology and modifiable risk factors for atrial fibrillation","volume":"20","author":"Elliott","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2024.113403_b0020","doi-asserted-by":"crossref","unstructured":"G. Hindricks, T. Potpara, N. Dagres, E. Arbelo, J.J. Bax, C. Blomstr\u00f6m-Lundqvist, G. Boriani, M. Castella, G.-A. Dan, P.E. Dilaveris, L. Fauchier, G. Filippatos, J.M. Kalman, M. La Meir, D.A. Lane, J.-P. Lebeau, M. Lettino, G.Y.H. Lip, F.J. Pinto, G.N. Thomas, M. Valgimigli, I.C. Van Gelder, B.P. Van Putte, C.L. Watkins, E.S.C.S.D. Group, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, European Heart J. 42(5) (2021) 373\u2013498.","DOI":"10.1093\/eurheartj\/ehab648"},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0025","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1038\/srep11427","article-title":"Mitochondrial oxidative stress promotes atrial fibrillation","volume":"5","author":"Xie","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.113403_b0030","doi-asserted-by":"crossref","unstructured":"X. Zhou, S.C. Dudley, Evidence for inflammation as a driver of atrial fibrillation 7 (2020).","DOI":"10.3389\/fcvm.2020.00062"},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/joa3.12473","article-title":"Role of inflammation in atrial fibrillation: a comprehensive review of current knowledge","volume":"37","author":"Nso","year":"2021","journal-title":"J. Arrhythmia"},{"issue":"4","key":"10.1016\/j.intimp.2024.113403_b0040","first-page":"233","article-title":"Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?","volume":"14","author":"Platonov","year":"2017","journal-title":"J. Geriatric Cardiol.: JGC"},{"key":"10.1016\/j.intimp.2024.113403_b0045","doi-asserted-by":"crossref","unstructured":"Y. Liu, H. Lv, R. Tan, X. An, X.-H. Niu, Y.-J. Liu, X. Yang, X. Yin, Y.-L. Xia, Platelets promote Ang II (Angiotensin II)-induced atrial fibrillation by releasing TGF-\u03b21 (transforming growth factor-\u03b21) and interacting with fibroblasts 76(6) (2020) 1856\u20131867.","DOI":"10.1161\/HYPERTENSIONAHA.120.15016"},{"key":"10.1016\/j.intimp.2024.113403_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.583570","article-title":"Apelin inhibits angiotensin II-induced atrial fibrosis and atrial fibrillation via TGF-\u03b21\/Smad2\/\u03b1-SMA pathway","volume":"11","author":"Lv","year":"2020","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113403_b0055","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s11010-021-04082-9","article-title":"Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines","volume":"476","author":"Babapoor-Farrokhran","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2024.113403_b0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12079-020-00553-8","article-title":"HIF-hypoxia signaling in skeletal muscle physiology and fibrosis","volume":"14","author":"Valle-Tenney","year":"2020","journal-title":"J. Cell Commun. Signaling"},{"issue":"9","key":"10.1016\/j.intimp.2024.113403_b0065","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5551\/jat.RV17009","article-title":"The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases","volume":"24","author":"Abe","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0070","doi-asserted-by":"crossref","first-page":"8897","DOI":"10.1080\/21655979.2021.1988368","article-title":"LRG1 promotes hypoxia-induced cardiomyocyte apoptosis and autophagy by regulating hypoxia-inducible factor-1\u03b1","volume":"12","author":"Feng","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.intimp.2024.113403_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105415","article-title":"Pathophysiology and therapeutic relevance of PI3K(p110\u03b1) protein in atrial fibrillation: a non-interventional molecular therapy strategy","volume":"165","author":"Ezeani","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.113403_b0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11010-022-04526-w","article-title":"PI3K(p110\u03b1) as a determinant and gene therapy for atrial enlargement in atrial fibrillation","volume":"478","author":"Ezeani","year":"2023","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12872-019-1013-7","article-title":"The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.intimp.2024.113403_b0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2022.03.005","article-title":"Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: evidence for potential off-target effects","volume":"167","author":"Dyck","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113403_b0095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/dom.12829","article-title":"C.-R.T.C.G. on behalf of the, rationale, design and baseline characteristics of the CANagliflozin cardioVascular assessment study-renal (CANVAS-R): a randomized, placebo-controlled trial","volume":"19","author":"Neal","year":"2017","journal-title":"Diabetes Obesity Metabolism"},{"issue":"4","key":"10.1016\/j.intimp.2024.113403_b0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.intimp.2024.113403_b0105","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.intimp.2024.113403_b0110","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113403_b0115","unstructured":"J.J. McMurray, S.D. Solomon, S.E. Inzucchi, L. K\u00f8ber, M.N. Kosiborod, F.A. Martinez, P. Ponikowski, M.S. Sabatine, I.S. Anand, J.J. B\u011blohl\u00e1vek, Dapagliflozin in patients with heart failure and reduced ejection fraction 381(21) (2019) 1995\u20132008."},{"key":"10.1016\/j.intimp.2024.113403_b0120","doi-asserted-by":"crossref","unstructured":"C. Wanner, S.E. Inzucchi, J.M. Lachin, D. Fitchett, M. von Eynatten, M. Mattheus, O.E. Johansen, H.J. Woerle, U.C. Broedl, B.J. Zinman, Empagliflozin and progression of kidney disease in type 2 diabetes 375(4) (2016) 323\u2013334.","DOI":"10.1056\/NEJMoa1515920"},{"issue":"4","key":"10.1016\/j.intimp.2024.113403_b0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113403_b0130","series-title":"Taurine 10","first-page":"821","article-title":"Taurine prevents the electrical remodeling in Ach-CaCl2 induced atrial fibrillation in rats","author":"Yang","year":"2017"},{"key":"10.1016\/j.intimp.2024.113403_b0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2016.05.026","article-title":"Ranolazine improves oxidative stress and mitochondrial function in the atrium of acetylcholine-CaCl2 induced atrial fibrillation rats","volume":"156","author":"Zou","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.113403_b0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fphys.2012.00174","article-title":"Effects of acetylcholine and noradrenalin on action potentials of isolated rabbit sinoatrial and atrial myocytes","volume":"3","author":"Verkerk","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2024.113403_b0145","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3389\/fphys.2018.01380","article-title":"Calcium in the pathophysiology of atrial fibrillation and heart failure","volume":"9","author":"Denham","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2024.113403_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172488","article-title":"Calcium overload-induced arrhythmia is suppressed by farnesol in rat heart","volume":"859","author":"Souza","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113403_b0155","first-page":"1","article-title":"Establishment of artial fibrillation model in SD rats","volume":"26","author":"Chen","year":"2009","journal-title":"Lab. Anim. Sci."},{"issue":"19","key":"10.1016\/j.intimp.2024.113403_b0160","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jacc.2014.05.077","article-title":"Atrial fibrillation promotion with long-term repetitive obstructive sleep Apnea in a rat model","volume":"64","author":"Iwasaki","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113403_b0165","doi-asserted-by":"crossref","first-page":"e006717","DOI":"10.1161\/JAHA.117.006717","article-title":"Concomitant obesity and metabolic syndrome add to the atrial arrhythmogenic phenotype in male hypertensive rats","volume":"6","author":"Hohl","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.intimp.2024.113403_b0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable risk factors and atrial fibrillation","volume":"136","author":"Lau","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2024.113403_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.01218","article-title":"Rapid atrial pacing promotes atrial fibrillation substrate in unanesthetized instrumented rats","volume":"10","author":"Mulla","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2024.113403_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112317","article-title":"Arnebiae Radix prevents atrial fibrillation in rats by ameliorating atrial remodeling and cardiac function","volume":"248","author":"Zhou","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12933-019-0964-4","article-title":"Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet\/streptozotocin-induced diabetic rats","volume":"18","author":"Shao","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12933-021-01322-6","article-title":"The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats","volume":"20","author":"Daud","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113403_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071680","article-title":"Empagliflozin attenuates myocardial sodium and calcium dysregulation and reverses cardiac remodeling in streptozotocin-induced diabetic rats","volume":"20","author":"Lee","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0200","first-page":"41","article-title":"Prophylactic and therapeutic effects of oleuropein on reperfusion-induced arrhythmia in anesthetized rat","volume":"20","author":"Baharvand","year":"2016","journal-title":"Iran. Biomed. J."},{"issue":"4","key":"10.1016\/j.intimp.2024.113403_b0205","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12380","article-title":"miR-101a-3p overexpression prevents acetylcholine-CaCl(2)-induced atrial fibrillation in rats via reduction of atrial tissue fibrosis, involving inhibition of EZH2","volume":"24","author":"Zhu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2024.113403_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155017","article-title":"Qi-Po-Sheng-Mai granule ameliorates Ach-CaCl2 -induced atrial fibrillation by regulating calcium homeostasis in cardiomyocytes","volume":"119","author":"Shi","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1540-8167.2009.01591.x","article-title":"Age-related increase in atrial fibrillation induced by transvenous catheter-based atrial burst pacing: an in vivo rat model of inducible atrial fibrillation","volume":"21","author":"Xu","year":"2010","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.intimp.2024.113403_b0220","series-title":"Atrial Rhythms","first-page":"3","author":"Desmarais","year":"2018"},{"issue":"6","key":"10.1016\/j.intimp.2024.113403_b0225","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s10787-022-01058-z","article-title":"Escin suppresses immune cell infiltration and selectively modulates Nrf2\/HO-1, TNF-\u03b1\/JNK, and IL-22\/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice","volume":"30","author":"Elshal","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2024.113403_b0230","doi-asserted-by":"crossref","unstructured":"Y. Hokama, R.M. Nakamura, C-reactive protein: current status and future perspectives 1(1) (1987) 15\u201327.","DOI":"10.1002\/jcla.1860010104"},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0676.1990.tb00428.x","article-title":"Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver","volume":"10","author":"James","year":"1990","journal-title":"Liver"},{"issue":"7337","key":"10.1016\/j.intimp.2024.113403_b0240","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/bmj.324.7337.594","article-title":"ABC of clinical electrocardiography: atrial arrhythmias","volume":"324","author":"Goodacre","year":"2002","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.intimp.2024.113403_b0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ins.2018.07.063","article-title":"Computer-aided diagnosis of atrial fibrillation based on ECG Signals: a review","volume":"467","author":"Hagiwara","year":"2018","journal-title":"Inf. Sci."},{"issue":"14","key":"10.1016\/j.intimp.2024.113403_b0250","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/heartjnl-2013-305149","article-title":"The ECG as a tool to determine atrial fibrillation complexity","volume":"100","author":"Lankveld","year":"2014","journal-title":"Heart"},{"issue":"2 Suppl 1","key":"10.1016\/j.intimp.2024.113403_b0255","first-page":"25","article-title":"P Wave Dispersion (PWD) as a predictor of Atrial Fibrillation (AF)","volume":"5","author":"Elmoniem","year":"2011","journal-title":"Int. J. Health Sci."},{"key":"10.1016\/j.intimp.2024.113403_b0260","article-title":"Investigating the association between P wave duration and atrial fibrillation recurrence after radiofrequency ablation in early persistent atrial fibrillation patients","volume":"351","author":"Miao","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113403_b0265","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.hroo.2022.12.009","article-title":"Prolonged PR interval and incidence of atrial fibrillation, heart failure admissions, and mortality in patients with implanted cardiac devices: a real-world survey","volume":"4","author":"Yarmohammadi","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.intimp.2024.113403_b0270","doi-asserted-by":"crossref","unstructured":"J. Heijman, N. Voigt, S. Nattel, D. Dobrev, Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression 114(9) (2014) 1483\u20131499.","DOI":"10.1161\/CIRCRESAHA.114.302226"},{"issue":"21","key":"10.1016\/j.intimp.2024.113403_b0275","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jacc.2011.05.061","article-title":"Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age","volume":"58","author":"Platonov","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11\u201312","key":"10.1016\/j.intimp.2024.113403_b0280","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/10715762.2018.1500696","article-title":"Oxidative stress and atrial fibrillation: an update","volume":"52","author":"Korantzopoulos","year":"2018","journal-title":"Free Radic. Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.113403_b0285","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCEP.114.001752","article-title":"Atrial fibrosis and conduction slowing in the left atrial appendage of patients undergoing thoracoscopic surgical pulmonary vein isolation for atrial fibrillation","volume":"8","author":"Krul","year":"2015","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113403_b0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacep.2017.05.002","article-title":"Fibrosis and atrial fibrillation: computerized and optical mapping; a view into the human atria at submillimeter resolution","volume":"3","author":"Hansen","year":"2017","journal-title":"JACC. Clin. Electrophysiol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113403_b0295","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-008-9803-8","article-title":"Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats","volume":"317","author":"Zhao","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2024.113403_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110123","article-title":"Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-\u03b2","volume":"87","author":"Jim\u00e9nez-Uribe","year":"2021","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.intimp.2024.113403_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044004","article-title":"Fibrosis: types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation","author":"Antar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2024.113403_b0315","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.molmed.2011.05.007","article-title":"Inflammatory pathways underlying atrial fibrillation","volume":"17","author":"Friedrichs","year":"2011","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0320","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-7-16","article-title":"Mechanisms of tumor necrosis factor-\u03b1-induced interleukin-6 synthesis in glioma cells","volume":"7","author":"Tanabe","year":"2010","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.intimp.2024.113403_b0330","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/14017430802651803","article-title":"Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation","volume":"43","author":"Qu","year":"2009","journal-title":"Scand. Cardiovascular J.: SCJ"},{"key":"10.1016\/j.intimp.2024.113403_b0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.758157","article-title":"Interleukin-6-mediated-Ca(2+) handling abnormalities contributes to atrial fibrillation in sterile pericarditis rats","volume":"12","author":"Liao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113403_b0340","doi-asserted-by":"crossref","unstructured":"P.E. Lazzerini, F. Laghi\u2010Pasini, M. Acampa, U. Srivastava, I. Bertolozzi, B. Giabbani, F. Finizola, F. Vanni, A. Dokollari, M. Natale, G. Cevenini, E. Selvi, N. Migliacci, M. Maccherini, M. Boutjdir, P.L. Capecchi, Systemic inflammation rapidly induces reversible atrial electrical remodeling: the role of interleukin\u20106\u2013mediated changes in connexin expression 8(16) (2019) e011006.","DOI":"10.1161\/JAHA.118.011006"},{"issue":"7","key":"10.1016\/j.intimp.2024.113403_b0345","doi-asserted-by":"crossref","first-page":"e007208","DOI":"10.1161\/CIRCHEARTFAILURE.120.007208","article-title":"Natriuretic peptides, inflammation, and sounding the alarm","volume":"13","author":"Ramakrishnan","year":"2020","journal-title":"Circ. Heart Fail."},{"issue":"9","key":"10.1016\/j.intimp.2024.113403_b0350","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.intimp.2024.113403_b0355","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sinica B"},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","article-title":"Hypoxia-inducible factor 1 and cardiovascular disease","volume":"76","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113403_b0365","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.carpath.2008.11.001","article-title":"Atrial fibrillation is associated with cardiac hypoxia","volume":"19","author":"Gramley","year":"2010","journal-title":"Cardiovasc. Pathol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113403_b0370","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1253\/circj.CJ-09-0969","article-title":"Is structural remodeling of fibrillated atria the consequence of tissue hypoxia?","volume":"74","author":"Ogi","year":"2010","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.intimp.2024.113403_b0375","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5527\/wjn.v4.i3.367","article-title":"How tubular epithelial cells dictate the rate of renal fibrogenesis?","volume":"4","author":"Louis","year":"2015","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.intimp.2024.113403_b0380","doi-asserted-by":"crossref","first-page":"6114132","DOI":"10.1155\/2021\/6114132","article-title":"Contribution of oxidative stress to HIF-1-mediated profibrotic changes during the kidney damage","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.intimp.2024.113403_b0385","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00005-011-0132-3","article-title":"Targeting NF-\u03baB and HIF-1 pathways for the treatment of cancer: part II","volume":"59","author":"Wilczynski","year":"2011","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.intimp.2024.113403_b0390","doi-asserted-by":"crossref","unstructured":"Y. Jung, J.S. Isaacs, S. Lee, J. Trepel, Z.-G. Liu, L.J.B.J. Neckers, Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappaB activation 370(3) (2003) 1011\u20131017.","DOI":"10.1042\/bj20021279"},{"key":"10.1016\/j.intimp.2024.113403_b0395","doi-asserted-by":"crossref","unstructured":"S. Bonello, C. Z\u00e4hringer, R.S. BelAiba, T. Djordjevic, J. Hess, C. Michiels, T. Kietzmann, A. G\u00f6rlach, Reactive oxygen species activate the HIF-1\u03b1 promoter via a functional NF\u03baB site 27(4) (2007) 755\u2013761.","DOI":"10.1161\/01.ATV.0000258979.92828.bc"},{"issue":"6","key":"10.1016\/j.intimp.2024.113403_b0400","doi-asserted-by":"crossref","first-page":"H2528","DOI":"10.1152\/ajpheart.01077.2005","article-title":"Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells","volume":"290","author":"Schultz","year":"2006","journal-title":"American J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113403_b0405","first-page":"3979","article-title":"Empagliflozin and sacubitril\/valsartan reverse methotrexate cardiotoxicity by repressing oxidative stress and hypoxia in heart embryonic H9c2 cardiomyocytes - the role of morphology of mitochondria observed on electron microscopy","volume":"27","author":"Dogan","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113403_b0410","first-page":"303","article-title":"Calpain-I, calpastatin, caspase-3 and apoptosis in the human left atrium in rheumatic atrial fibrillation","volume":"34","author":"Chen","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.intimp.2024.113403_b0415","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41392-023-01497-2","article-title":"Interaction between neutrophil extracellular traps and cardiomyocytes contributes to atrial fibrillation progression","volume":"8","author":"He","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2024.113403_b0420","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202201159","article-title":"Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis","volume":"221","author":"Eskandari","year":"2022","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.intimp.2024.113403_b0425","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.12659\/MSM.895715","article-title":"Associations of MMP-2, BAX, and Bcl-2 mRNA and protein expressions with development of atrial fibrillation","volume":"22","author":"Diao","year":"2016","journal-title":"Med. Sci. Monitor: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.intimp.2024.113403_b0430","doi-asserted-by":"crossref","unstructured":"S. Moulin, A. Thomas, S. Wagner, M. Arzt, H. Dubouchaud, F. Lamarche, S. Bouyon, G. Vial, D. Godin-Ribuot, J.-L. P\u00e9pin, C. Arnaud, E. Belaidi, Intermittent hypoxia-induced cardiomyocyte death is mediated by HIF-1 dependent MAM disruption 11(8) (2022) 1462.","DOI":"10.3390\/antiox11081462"},{"key":"10.1016\/j.intimp.2024.113403_b0435","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2023.03.084","article-title":"Cx43 overexpression reduce the incidence of obstructive sleep apnea associated atrial fibrillation via the CaMK\u2161\u03b3\/HIF-1 axis","volume":"659","author":"Yang","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2024.113403_b0440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lfs.2016.10.018","article-title":"Role of phosphatidylinositol-4,5-bisphosphate 3-kinase signaling in vesicular trafficking","volume":"167","author":"Bhattacharya","year":"2016","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.intimp.2024.113403_b0445","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nn1300","article-title":"PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane","volume":"7","author":"Viard","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2024.113403_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172670","article-title":"Sirtuins as novel targets in the pathogenesis of airway inflammation in bronchial asthma","volume":"865","author":"Ma","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113403_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2022.103833","article-title":"Preventive empagliflozin activity on acute acetic acid-induced ulcerative colitis in rats via modulation of SIRT-1\/PI3K\/AKT pathway and improving colon barrier","volume":"91","author":"Zaghloul","year":"2022","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113403_b0460","first-page":"714","article-title":"Role of PDGFR-\u03b2\/PI3K\/AKT signaling pathway in PDGF-BB induced myocardial fbrosis in rats","volume":"6","author":"Fan","year":"2014","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.113403_b0465","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1159\/000479401","article-title":"PDGF promotes the Warburg effect in pulmonary arterial smooth muscle cells via activation of the PI3K\/AKT\/mTOR\/HIF-1\u03b1 signaling pathway","volume":"42","author":"Xiao","year":"2017","journal-title":"J. Cell. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.intimp.2024.113403_b0470","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"Laughner","year":"2001","journal-title":"Mol. Cell Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924019258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924019258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:32:14Z","timestamp":1736303534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924019258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":94,"alternative-id":["S1567576924019258"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113403","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin protects the heart from atrial fibrillation in rats through inhibiting the NF-\u03baB\/HIF-1\u03b1 regulatory axis and atrial remodeling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113403"}}